Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle M Kim

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Neuro-Oncology|June 8, 2022
Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO groupNorbert Galldiks, Karl-Josef Langen, Nathalie L Albert, et al.
Acta Oncologica (Stockholm, Sweden)|September 28, 2007
Clinical benefit of palliative radiation therapy in advanced gastric cancerMichelle M Kim, Vishal Rana, Nora A Janjan, et al.
Journal for Immunotherapy of Cancer|January 30, 2018
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshopAriel E Marciscano, Joshua M Walker, Heather M McGee, et al.
Urologic Oncology|January 5, 2024
Clinical significance of prostate cancer identified by transperineal standard template biopsy in men with nonsuspicious multiparametric magnetic resonance imagingDouglas M Dahl, Shulin Wu, Sharron X Lin, et al.
Biomolecules|July 8, 2016
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsBryan Oronsky, Jan Scicinski, Michelle M Kim, et al.
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Improvement in prostate cancer survival over time: a 20-year analysisMichelle M Kim, Karen E Hoffman, Lawrence B Levy, et al.
Medical Oncology (Northwood, London, England)|February 4, 2019
Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussionSteven C Weindorf, Alexander S Taylor, Chandan Kumar-Sinha, et al.
European Journal of Cancer (Oxford, England : 1990)|February 17, 2012
Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?Michelle M Kim, Karen E Hoffman, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgeryMichelle M Kim, Paul F Mansfield, Prajnan Das, et al.
Journal of Neuro-Oncology|February 2, 2018
Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastomaWilliam C Jackson, Christina I Tsien, Larry Junck, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Neuro-Oncology|June 8, 2022
Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO groupNorbert Galldiks, Karl-Josef Langen, Nathalie L Albert, et al.
Acta Oncologica (Stockholm, Sweden)|September 28, 2007
Clinical benefit of palliative radiation therapy in advanced gastric cancerMichelle M Kim, Vishal Rana, Nora A Janjan, et al.
Journal for Immunotherapy of Cancer|January 30, 2018
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshopAriel E Marciscano, Joshua M Walker, Heather M McGee, et al.
Urologic Oncology|January 5, 2024
Clinical significance of prostate cancer identified by transperineal standard template biopsy in men with nonsuspicious multiparametric magnetic resonance imagingDouglas M Dahl, Shulin Wu, Sharron X Lin, et al.
Biomolecules|July 8, 2016
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsBryan Oronsky, Jan Scicinski, Michelle M Kim, et al.
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Improvement in prostate cancer survival over time: a 20-year analysisMichelle M Kim, Karen E Hoffman, Lawrence B Levy, et al.
Medical Oncology (Northwood, London, England)|February 4, 2019
Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussionSteven C Weindorf, Alexander S Taylor, Chandan Kumar-Sinha, et al.
European Journal of Cancer (Oxford, England : 1990)|February 17, 2012
Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?Michelle M Kim, Karen E Hoffman, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgeryMichelle M Kim, Paul F Mansfield, Prajnan Das, et al.
Journal of Neuro-Oncology|February 2, 2018
Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastomaWilliam C Jackson, Christina I Tsien, Larry Junck, et al.
Pageof 13